BONESUPPORT HOLDING AB (BOEUF)
23.49
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
BONESUPPORT Net Income (Quarterly) : 8.743M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.743M |
| March 31, 2026 | 5.840M |
| December 31, 2025 | 4.693M |
| September 30, 2025 | 3.626M |
| June 30, 2025 | 5.493M |
| March 31, 2025 | 0.9769M |
| December 31, 2024 | 5.001M |
| September 30, 2024 | 2.933M |
| June 30, 2024 | 2.566M |
| March 31, 2024 | 2.101M |
| December 31, 2023 | 1.006M |
| September 30, 2023 | 21.16M |
| June 30, 2023 | 0.4941M |
| March 31, 2023 | 0.0295M |
| December 31, 2022 | -1.915M |
| September 30, 2022 | -1.417M |
| June 30, 2022 | -1.655M |
| March 31, 2022 | -1.753M |
| December 31, 2021 | -2.731M |
| September 30, 2021 | -1.627M |
| June 30, 2021 | -3.215M |
| Date | Value |
|---|---|
| March 31, 2021 | -2.406M |
| December 31, 2020 | -3.154M |
| September 30, 2020 | -2.394M |
| June 30, 2020 | -2.442M |
| March 31, 2020 | -3.035M |
| December 31, 2019 | -4.247M |
| September 30, 2019 | -3.461M |
| June 30, 2019 | -5.074M |
| March 31, 2019 | -4.259M |
| December 31, 2018 | -5.044M |
| September 30, 2018 | -6.572M |
| June 30, 2018 | -4.401M |
| March 31, 2018 | -4.163M |
| December 31, 2017 | -6.172M |
| September 30, 2017 | -2.812M |
| June 30, 2017 | -2.676M |
| March 31, 2017 | -3.485M |
| December 31, 2016 | -3.827M |
| September 30, 2016 | -4.086M |
| June 30, 2016 | -2.832M |
| March 31, 2016 | -2.063M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| BioInvent International AB | -13.04M |
| Hansa Biopharma AB | -27.82M |
| BioArctic AB | 23.24M |
| Swedish Orphan Biovitrum AB | 117.25M |
| Diamyd Medical AB | -13.67M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 37.99M |
| Total Expenses (Quarterly) | 29.24M |
| EPS Diluted (Quarterly) | 0.1309 |
| Enterprise Value | 1.494B |
| Gross Profit Margin (Quarterly) | 90.81% |
| Profit Margin (Quarterly) | 23.02% |
| Earnings Yield | 1.46% |
| Operating Earnings Yield | 2.10% |
| Normalized Earnings Yield | 1.439 |